News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Webster Stephen W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Webster Stephen W (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 18,450 options to buy
@ $13, valued at
$239.9k
|
|
| 06/01/2023 |
4
| Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 12,100 options to buy
@ $31.83, valued at
$385.1k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 10,482 options to buy
@ $9.54, valued at
$100k
|
|
| 12/19/2022 |
4
| Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 16,800 options to buy
@ $0.97, valued at
$16.3k
|
|
| 08/04/2022 |
4
| Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 7,826 shares
@ $0.19, valued at
$1.5k
|
|
| 06/24/2022 |
4
| Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $4.77, valued at
$68k
|
|
| 06/23/2022 |
4
| Webster Stephen W (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 16,475 options to buy
@ $12.73, valued at
$209.7k
|
|
| 03/25/2022 |
4
| Webster Stephen W (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 7,800 options to buy
@ $28.8, valued at
$224.6k
|
|
| 12/10/2021 |
4
| Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 12,100 options to buy
@ $5.21, valued at
$63k
|
|
| 08/04/2021 |
4
| Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 777 shares
@ $1.2, valued at
$932.4 |
|
| 07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $8.21, valued at
$117k
|
|
| 12/11/2020 |
4
| Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 12,100 options to buy
@ $31.83, valued at
$385.1k
|
|
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $24.13, valued at
$343.9k
|
|
| 05/04/2020 |
4
| Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 10,482 options to buy
@ $9.54, valued at
$100k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 6,102 shares
@ $114.5, valued at
$698.7k
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 28,000 options to buy
@ $50.55, valued at
$1.4M
Disposed/sold 25,000 options to buy
@ $56.17, valued at
$1.4M
Disposed/sold 55,000 options to buy
@ $40.44, valued at
$2.2M
Disposed/sold 60,000 options to buy
@ $68.45, valued at
$4.1M
Disposed/sold 106,015 options to buy
@ $3.45, valued at
$365.8k
Disposed/sold 19,500 restricted stock units
@ $0 |
|
| 08/01/2019 |
4
| Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 35,000 options
@ $0 |
|
| 06/17/2019 |
4
| Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 22,000 options to buy
@ $15.57, valued at
$342.5k
|
|
| 01/23/2019 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 634 shares
@ $45.08, valued at
$28.6k
Paid exercise price by delivering 629 shares
@ $45.08, valued at
$28.4k
Exercised 1,750 restricted stock units
@ $0
Exercised 2,000 restricted stock units
@ $0 |
|
| 01/17/2019 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $42.73, valued at
$1.5M
Granted 10,000 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2018 |
4
| Webster Stephen W (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Bought 8,000 shares
@ $5.214, valued at
$41.7k
|
|
| 05/23/2018 |
4
| Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Bought 8,000 shares
@ $4.59, valued at
$36.7k
|
|
| 05/04/2018 |
4
| Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 29,000 options
@ $0 |
|
| 01/22/2018 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 635 shares
@ $50.55, valued at
$32.1k
Granted 28,000 options to buy
@ $50.55, valued at
$1.4M
Granted 8,000 restricted stock units
@ $0
Exercised 1,750 restricted stock units
@ $0 |
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2017 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $70.14, valued at
$701.4k
Exercised 10,000 options to buy
@ $3.45, valued at
$34.5k
|
|
| 09/19/2017 |
4
| Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 10,100 options
@ $0 |
|
| 08/15/2017 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $79.38, valued at
$793.8k
Exercised 10,000 options to buy
@ $3.45, valued at
$34.5k
|
|
| 08/02/2017 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 2,337 shares
@ $71.12, valued at
$166.2k
Exercised 2,337 options to buy
@ $3.45, valued at
$8.1k
|
|
| 06/27/2017 |
4
| Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics Plc|
Txns:
| Acquired 20,200 options
@ $0
Acquired 10,100 options
@ $0 |
|
| 06/21/2017 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 7,663 shares
@ $60, valued at
$459.8k
Exercised 7,663 options to buy
@ $3.45, valued at
$26.4k
|
|
| 04/26/2017 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc. |
|
|
|